Teza Capital Management LLC Has $1.74 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

Teza Capital Management LLC lowered its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 17.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 18,921 shares of the medical device company’s stock after selling 4,122 shares during the quarter. Teza Capital Management LLC’s holdings in Cooper Companies were worth $1,739,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Toronto Dominion Bank increased its stake in shares of Cooper Companies by 5.9% in the 4th quarter. Toronto Dominion Bank now owns 70,696 shares of the medical device company’s stock valued at $6,499,000 after purchasing an additional 3,924 shares during the last quarter. Select Equity Group L.P. increased its stake in shares of Cooper Companies by 56.1% in the 4th quarter. Select Equity Group L.P. now owns 262,809 shares of the medical device company’s stock valued at $24,160,000 after purchasing an additional 94,466 shares during the last quarter. Shell Asset Management Co. increased its stake in shares of Cooper Companies by 15.5% in the 4th quarter. Shell Asset Management Co. now owns 946 shares of the medical device company’s stock valued at $87,000 after purchasing an additional 127 shares during the last quarter. Sherbrooke Park Advisers LLC bought a new position in shares of Cooper Companies in the 4th quarter valued at $765,000. Finally, Silvercrest Asset Management Group LLC bought a new position in shares of Cooper Companies in the 4th quarter valued at $221,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

COO has been the topic of several recent analyst reports. Citigroup decreased their price target on Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. Stifel Nicolaus decreased their price target on Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Robert W. Baird decreased their price target on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research note on Friday, March 7th. Finally, BNP Paribas upgraded Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Trading Up 1.8%

NASDAQ COO opened at $82.92 on Friday. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a twelve month low of $69.81 and a twelve month high of $112.38. The company has a market cap of $16.58 billion, a price-to-earnings ratio of 42.52, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08. The business’s fifty day moving average is $80.19 and its 200 day moving average is $90.10.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. The firm had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.